23 minute listen time
11 August 2021
Subscribe to Talking Property with CBRE

APPLE_button_165x40
SPOTIFY_button_165x40

 

The life science industry has seen rapid growth within our region in recent years, supported by expanding demand from Asia Pacific’s large and ageing population and supportive government policies. While global pharmaceutical giants from the U.S. and Europe still dominate the market, Asia Pacific based firms are expanding rapidly, which account for 28% of the global revenue in 2020.  

In this episode of Talking Property, Henry Chin CBRE’s Global Head of Investor Thought Leadership sits down with Mark Coster Head of Capital Markets, Pacific and David Keenan National Director of Science & Research, Australia. Together, they explore the latest trends, demand drivers, corporate real estate strategies and investment opportunities in major life sciences hubs across the Pacific. 

VIEW THE APAC LIFE SCIENCES REPORT


 

Featuring


Dr. Henry Chin, Global Head of Investor Thought Leadership, Head of Research APAC, CBRE

Dr. Henry Chin leads CBRE’s investor thought leadership across all regions and oversees all research activity in Asia Pacific. After joining CBRE in 2014, Henry was promoted to CBRE’s Asia Pacific Strategic Group, the board which oversees CBRE’s strategic direction in the region, in 2016. From 2019-2020 he also served as Head of Research, EMEA.

VIEW PROFILE


 Mark Coster, Head of Capital Markets, Pacific, CBRE

Mark has been with CBRE for 20 years. His roles have included experience in its valuations and the capital market businesses.  Mark has responsibility for CBRE’s Capital Markets business in Australia and New Zealand.  Mark is passionate about client service and delivering a culture and platform at CBRE that generates the best possible outcomes for its clients.  Mark also has extensive experience in cross border business (Asia, EMEA and the US). 

VIEW PROFILE


 David Keenan, National Director Science & Research, Project Management, CBRE

David has significant experience across Australia’s Health, Research and Education sectors. In his role, he delivers leadership to projects across the country and has a thorough understanding of planning, design and operational issues of these often very complex and highly serviced facilities.  He regularly writes on the sector and is passionate about sustainable design and improved performance for critical and complex social infrastructure facilities.

VIEW PROFILE

 

More from CBRE

A New Era of Growth in Life Sciences

New types of properties are needed to facilitate the growth of pharmaceutical, biotechnology, medical equipment, food sciences and healthcare industries in Asia Pacific.

An Australian Whitecoat Whitepaper

Australia’s tertiary institutions remain critical to Australia’s infrastructure and a key piece of the life sciences puzzle which has been rapidly emerging sector in recent year.

Is History Repeating for Healthcare

Even amidst one of the most challenging economic environments in Australian history, property within the country’s healthcare investment market continues to transact.